BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7617692)

  • 1. The effect of in utero administration of buthionine sulfoximine on rat development.
    Reyes E; Ott S; Robinson B; Contreras R
    Pharmacol Biochem Behav; 1995 Apr; 50(4):491-7. PubMed ID: 7617692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of buthionine sulfoximine on the outcome of the in utero administration of alcohol on fetal development.
    Reyes E; Ott S
    Alcohol Clin Exp Res; 1996 Oct; 20(7):1243-51. PubMed ID: 8904978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of in vivo glutathione depletion with buthionine sulfoximine on rat embryo development.
    Hales BF; Brown H
    Teratology; 1991 Sep; 44(3):251-7. PubMed ID: 1948763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buthionine sulfoximine treatment impairs rat diaphragm function.
    Morales CF; Anzueto A; Andrade F; Brassard J; Levine SM; Maxwell LC; Lawrence RA; Jenkinson SG
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):915-9. PubMed ID: 7908245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of total ovarian glutathione content in the rat.
    Jarrell JF; Sevcik M; Stuart G
    Reprod Toxicol; 1992; 6(2):133-5. PubMed ID: 1350476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of plasma estradiol and progesterone concentrations by buthionine sulfoximine in female rats.
    Kang YJ; Uthus EO
    Biochem Pharmacol; 1996 Feb; 51(4):567-70. PubMed ID: 8619904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of glutathione by L-buthionine sulfoximine does not promote inactivation of myo-inositol transport in cultured bovine lens epithelial cells.
    Cammarata PR; Tse D; Yorio T
    Curr Eye Res; 1991 Apr; 10(4):321-30. PubMed ID: 1676962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile of procarbazine-induced embryotoxicity in an embryo hepatocyte co-culture system and after in utero glutathione depletion.
    Ebron-McCoy MT; Nichols HP; Andrews JE; Kavlock RJ
    Teratog Carcinog Mutagen; 1995; 15(1):33-42. PubMed ID: 7604390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential glutathione depletion by L-buthionine-S,R-sulfoximine in rat embryo versus visceral yolk sac in vivo and in vitro.
    Harris C; Fantel AG; Juchau MR
    Biochem Pharmacol; 1986 Dec; 35(24):4437-41. PubMed ID: 3790163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R; Schiestl RH
    Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
    Kera Y; Ohbora Y; Komura S
    Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC; Harris JW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic effects of acute glutathione depletion by buthionine sulfoximine and dimethylfumarate on murine mammary carcinoma cells.
    Dethlefsen LA; Lehman CM; Biaglow JE; Peck VM
    Radiat Res; 1988 May; 114(2):215-24. PubMed ID: 3375425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buthionine sulfoximine-induced cytostasis does not correlate with glutathione depletion.
    Kang YJ; Enger MD
    Am J Physiol; 1992 Jan; 262(1 Pt 1):C122-7. PubMed ID: 1733228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular administration of L-buthionine sulfoximine: a method for depleting brain glutathione.
    Pileblad E; Magnusson T
    J Neurochem; 1989 Dec; 53(6):1878-82. PubMed ID: 2809598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.